ARCHIVES

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

This article is from The Cancer Letter archive.

Vol. 20 No. 38 | October 7, 1994

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Against Routine Adjuvant Chemo For Stage II Colon Cancer

August 27, 2004

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

Texas Cancer Plan Features Big Hike in Cigarette Tax

September 19, 1986